Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.11.4617

Association Between the (GT)n Polymorphism of the HO-1 Gene Promoter Region and Cancer Risk: a Meta-analysis  

Zhang, Ling (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education)
Song, Fang-Fang (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education)
Huang, Yu-Bei (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education)
Zheng, Hong (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education)
Song, Feng-Ju (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education)
Chen, Ke-Xin (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.11, 2014 , pp. 4617-4622 More about this Journal
Abstract
Background: Several studies have previously focused on associations between the (GT)n repeat polymorphism of the heme oxygenase-1 (HO-1) gene promoter region and risk of cancers, but results are complex. We conducted the present meta-analysis to integrate relevant findings and evaluate the association between HO-1(GT)n repeat polymorphism and cancer susceptibility. Materials and Methods: Published literature was retrieved from the PubMed/MEDLINE, EMBASE and ISI Web of Science databases before November 2013. For all alleles and genogypes, odds ratios were pooled to assess the strength of the associations using either fixed-effects or random-effects models according to heterogeneity. Subgroup analysis was conducted according to ethnicity and histopathology. Results: A total of 10 studies involving 2,367 cases and 2,870 controls were identified. The results showed there was no association between HO-1 (GT)n repeat polymorphism and the cancer risk both at the allelic and genotypic level. However, in the stratified analysis, we observed an increased risk of squamous cell carcinoma in persons carrying the LL genotype and the LL+LS genotype as compared with those carrying the SS genotype. When the LS and SS genotypes were combined, the odds ratio for squamous cell carcinoma in LL-genotype carriers, were also significantly increased. No publication bias was observed. Conclusions: The LL genotype and L-allele carrying genotypes (LL+LS) of HO-1 (GT)n repeat polymorphism are potential genetic factors for developing squamous cell carcinoma. More large and well-designed studies are required for further validations.
Keywords
Heme oxygenase-1; polymorphism; cancer; meta-analysis;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Aruoma OI, Grootveld M, Bahorun T (2006). Free radicals in biology and medicine: from inflammation to bioteclmology. Biofactors, 27, 1-3.   DOI
2 Berberat PO, Dambrauskas Z, Gulbinas A, et al (2005). Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res, 11, 3790-8.   DOI   ScienceOn
3 Chang KW, Lee TC, Yeh WI, et al (2004). Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer, 91, 1551-5.   DOI
4 DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7 , 177-88.   DOI   ScienceOn
5 Chian S, Li YY, Wang XJ, et al (2014). Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the nrf2 pathway. Asian Pac J Cancer Prev, 15, 2911-6.   과학기술학회마을   DOI   ScienceOn
6 Datta D, Banerjee P, Gasser M, Waaga-Gasser AM, Pal S (2010). CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1. J BioI Chem, 285, 36842-8.   DOI
7 Davies KJ (1995). Oxidative stress: the paradox of aerobic life. Biochem Soc Symp, 61, 1-31.
8 Deshane J, Wright M, Agarwal A (2005). Heme oxygenase-1 expression in disease states. Acta Biochim Pol, 52, 273-84.
9 Egger M, Davey Smith G, Sclmeider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI   ScienceOn
10 Exner M, Minar E, Wagner 0, Schillinger M (2004). The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med, 37, 1097-104.   DOI
11 Hu JL, Li ZY, Liu W, et al (2010). Polymorphism in heme oxygenase-l (HO-1) promoter and alcohol are related to the risk of esophageal squamous cell carcinoma on Chinese males. Neoplasma, 57, 86-92.   DOI
12 Higgins JPT, Green S, eds (2009). Cochrane Handoook for Systematic Reviews of Interventions, Version 5.0.2 [Updated September 2009]. The Cochrane Collaooration, Oxford.
13 Hong CC, Ambrosone CB, Ahn J, et al (2007). Genetic variability in iron-related oxidative stress pathways (Nrf2, NQO1, NOS3, and HO-1), ironintake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev , 16, 1784-94.   DOI   ScienceOn
14 Kikuchi A, Yamaya M, Suzuki S, et al (2005). Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-l gene promoter polymorphism. Hum Genet, 116, 354-60.   DOI
15 Jiraskova A, Novotny J, Novotny L, et al (2012). Association of serum bilirubin and promoter variations in HMOX1and UGT1A1 genes with sporadic colorectal cancer. Int J Cancer, 131, 1549-55.   DOI
16 Jozkowicz A, Was H, Dulak J (2007). Heme oxygenase-1 in tumors: Is it a false friend? Antioxid Redox Signal, 9, 2099-117.   DOI
17 Kimpara T, TakedaA, Watanabe K, et al (1997). Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet, 100, 145-7.   DOI   ScienceOn
18 Li Q, Wang JM, Peng Y, et al (2013). Association of DNA base-excision repair XRCC1 , OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population. Asian Pac J Cancer Prev, 14, 5145-51.   과학기술학회마을   DOI   ScienceOn
19 Lin SC, Liu CJ, Yeh WI, et al (2006). Functional polymorphism in NFKBl promoter is related to the risks of oral squamous cell carcinoma occuning on older male areca (betel) chewers. Cancer Lett, 243, 47-54.   DOI   ScienceOn
20 Li Y, Ambrosone CB, McCullough MJ, et al (2009). Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis, 30, 777-84.   DOI   ScienceOn
21 Lo SS, Lin SC, Wu CW, et al (2007). Heme Oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion. Ann Surg Oncol, 14, 2250-6.   DOI
22 Luo H, Li Z, Qing Y, et al (2014). Single nucleotide polymorphisms of DNA base-excision repair genes (APEl, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population. Asian Pac J Cancer Prev, 15, 1133-40.   과학기술학회마을   DOI   ScienceOn
23 Murakami A, Fujimori Y, Yoshikawa Y, et al (2012). Heme Oxygenase-1promoter polymorphism is associated with risk of malignant mesothelioma. Lung, 190, 333-7.   DOI
24 Maines MD (1997). The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol, 37,517-54.   DOI   ScienceOn
25 Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
26 Marcos M, Gomez-Munuera M, Pastor I, Gonzalez-Sanniento R, Laso FJ (2009). Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am J Epidemiol, 170, 948-56.   DOI
27 Song F, Li X, Zhang M, et al (2009). Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. Am J Epidemiol, 170, 747-56.   DOI
28 Nulm P, Kunzli BM, Hennig R, et al (2009). Heme oxygenase-1 and its metaoolites affect pancreatic tumor growth in vivo. Mol Cancer, 8, 37   DOI
29 Okamoto I, Krogler J, Endler G, et al (2006). A microsatellite polymorphism in the heme oxygenase-l gene promoteris associated withriskfor melanoma. Int J Cancer, 119, 1312-5.   DOI
30 Sawa T, Mounawar M, Tatemichi M, et al (2008). Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-l and the inducible nitric oxide synthase gene promoters. Cancer Lell, 269, 78-84.   DOI
31 Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-12.   DOI   ScienceOn
32 Vashist YK, Uzunoglu G, Cataldegirmen G, et al (2009). Haeme oxygenase-1 promoter polymorphism is an independent prognostic marker of gastrointestinal stromal tumour. Histopathology, 54, 303-8.   DOI   ScienceOn
33 Vashist YK, Uzungolu G, Kutup A, et al (2011). Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer. J Surg Oncol, 104, 305-11   DOI
34 Woolf B (1955). On estimating the relation between blcxxl group and disease. Ann Hum Genet, 19,251-3.   DOI   ScienceOn
35 Sacca P, Meiss R, Casas G, et al (2007). Nuclear translocation of haeme oxygenase-l is associated to prostate cancer. Br J Cancer, 97, 1683-9.   DOI
36 Yamada N, Yamaya M, Okinaga S, et al (2000). Microsatellite polymorphism in the heme oxygenase-l gene promoter is associated with susceptibility to emphysema. Am J Hum Genet, 66, 187-95.   DOI   ScienceOn
37 Hirai H, Kubo H, Yamaya M, et al (2003). Microsatellite polymorphism in heme oxygenase-l gene promoter is associated with susceptibility to oxidant-induced apoptosis inlymphoblastoid cell lines. Blood, 102, 1619-24.   DOI